ATLAS All-in-One

Composition, choice of forms and safety profile

Information for doctors, pharmacists and therapists

  • 120 capsules, 95 g
  • Daily serving 4 capsules with a sip of water
  • Made in Lengau, Upper Austria
  • Formula as at 8 July 2026
  • Document as at 19 August 2026
  • Dr med univ Kurosch Borhanian
    Specialist in general and visceral surgery

ATLAS All-in-One is a food supplement, not a medicinal product. This document is addressed to doctors, pharmacists and members of therapeutic professions. It places composition, the nutrient compounds used and amounts in a professional context and is not advertising directed at consumers. It does not replace individual advice.

§ 0 The composition

All figures per daily serving, taken from the printed label.

Vitamins and minerals · 18 components
ComponentChemical formAmount% NRV
Thiamine (B1)Thiamine mononitrate2.6 mg236
Riboflavin (B2)Riboflavin 5′-phosphate sodium2.6 mg186
Niacin (B3)Nicotinamide16 mg NE100
Pantothenic acidCalcium D-pantothenate12 mg200
Vitamin B6Pyridoxal 5'-phosphate2.3 mg164
BiotinD-biotin104 µg208
Folate(6S)-5-methyltetrahydrofolic acid glucosamine salt400 µg200
Vitamin B12Methylcobalamin75 µg3.000
Vitamin CCalcium L-ascorbate141 mgL-ascorbyl 6-palmitate20 mg161 mg201
Vitamin DCholecalciferol50 µg2,000 IU1.000
Vitamin KMenaquinone (K2)150 µg200
Vitamin EMixed tocopherols1.7 mg α-TED-alpha-tocopheryl acetate14 mg15.7 mgα-TE131
MagnesiumMagnesium malate96 mgMagnesium bisglycinate complex (MagChel®)80 mg176 mg47
ZincZinc bisglycinate10 mg100
ManganeseManganese gluconate2 mg100
SeleniumSodium selenite100 µg182
ChromiumChromium(III) chloride50 µg125
MolybdenumSodium molybdate101 µg202
Further components · 17
ComponentForm or originAmount
Nicotinamide ribosideNicotinamide riboside chloride300 mg
Coenzyme Q10Coenzyme Q10150 mg
trans-Resveratroltrans-Resveratrol150 mg
AshwagandhaWinter cherry extractof which 5 mg withanolides90 mg
Grape seedExtractof which 71 mg proanthocyanidins, 37.5 mg OPC75 mg
Green teaExtractof which 71 mg polyphenols, 33 mg EGCG75 mg
Acetyl-L-carnitineAcetyl-L-carnitine hydrochloride64 mg
Alpha-lipoic acidAlpha-lipoic acid60 mg
RosehipExtract60 mg
Hop flowerExtractof which 1.5 mg xanthohumol30 mg
HericiumExtract, polysaccharides25 mg
CordycepsCordyceps sinensis, extract, polysaccharides24 mg
LuteinMarigold extract10 mg
QuercetinQuercetin phospholipid powder10 mg
AstaxanthinHaematococcus pluvialis, powder6 mg
TheobromineCocoa extract5 mg
ZeaxanthinMarigold extract1.3 mg

35 components. Capsule shell hydroxypropyl methylcellulose. Ashwagandha, Hericium and Cordyceps extract naturally contain sulphites. No iron, no iodine. Calcium is not declared as a nutrient; it occurs solely as a carrier salt in calcium L-ascorbate and calcium D-pantothenate.

§ 1 What the preparation is - and who it is not for

ATLAS All-in-One is a food supplement for daily intake over an extended period. It covers a broad basic requirement of vitamins and minerals and contains 17 further components alongside - coenzyme Q10, nicotinamide riboside, plant extracts, natural pigments (carotenoids).

It is not a therapy and not a substitute for targeted substitution. Anyone with a demonstrated deficiency needs a single preparation at the dose appropriate for it and monitoring of the course. A combination preparation can do neither: it doses for the basic requirement, not for a gap, and it cannot be titrated.

Who it is not intended for

  • Pregnant and breastfeeding women and persons under 18
  • Anyone consuming other products containing green tea on the same day
  • Anyone taking medicines without that intake having been discussed. § 6 names the constellations in which this discussion is not a formality but matters in substance

And one limitation that is on no label: anyone who is young, eats a varied diet and is under no particular strain will be able to expect little from a preparation of this breadth. The underlying idea is to supplement an already sensible diet, not to replace it - recognisable from the amounts (§ 2).

§ 2 Why 35 components

The obvious criticism of a preparation of this breadth is that breadth takes the place of a decision: put everything in and you are probably skimping on the doses.

The objection holds for part of this product category. For ATLAS it describes how it came about the wrong way round.

The number was not a specification. What was specified were 2 goals that limit each other:

  • As complete as possible. What is sensible and supported by sufficient literature should be in it.
  • As simple as possible to take. One serving daily, tasteless, with no preparation.

35 is therefore not a chosen figure but the result of that balance. Choosing a number would have been the more arbitrary decision.

And a third specification that determines every single amount

The preparation is designed to be taken daily over years. That is a different dosing problem from a time-limited intervention. Anyone taking something over years does not need a study dose - they need an amount that supplements a normal diet and stays safe over time.

2 figures in the declaration show this principle:

  • Magnesium: 176 mg, 47 % of the reference value - the only figure below 100 % in the table. It is not a technical limit; a higher amount would have been possible. It is the amount that supplements a balanced diet without replacing it.
  • Vitamin D: 50 µg (2,000 IU) - above the D-A-CH estimate of 20 µg for adults with no endogenous synthesis, at half the tolerable upper level of 100 µg derived by the EFSA. Here too more would be possible; here too duration is the argument (§ 4).

A preparation in which every figure sits at the upper edge is dosed to impress, not for the long run.

What could make a component fail

2 questions decided every substance, and both could come out negative: is it sufficiently evidenced? And: can an amount that makes sense over the long run be fitted into the volume available? Where either answer was no, the substance is not in it - regardless of how well it would have looked on a label. § 4 names 4 such decisions.

§ 3 The choice of forms

In a combination preparation the choice of compound decides the outcome as much as the amount does. The overview below names, for each component, the compound used and the compound otherwise predominantly used in this product category.

What this overview deliberately does not do: it evaluates neither side. Statements about better absorption of a compound are health claims within the meaning of Regulation (EC) No 1924/2006; no such claim is authorised for bioavailability. What is named is therefore what the compound is chemically and how it differs. The judgement is left to the reader.

ComponentUsedUsual alternativeChemical difference
Magnesium
Used
Magnesium malate · magnesium bisglycinate complex
Usual alternative
Magnesium oxide, carbonate
Chemical difference
Malate is an organic compound; in the bisglycinate complex, the brand-name raw material MagChel® (MAGNESIA GmbH), magnesium is bound to 2 glycine molecules (1 : 2), and according to the ingredient list the complex also contains magnesium oxide
Folate
Used
(6S)-5-methyltetrahydrofolic acid as glucosamine salt
Usual alternative
Folic acid
Chemical difference
The form that circulates in the blood. Folic acid is the synthetic precursor and is reduced enzymatically
Vitamin B12
Used
Methylcobalamin
Usual alternative
Cyanocobalamin
Chemical difference
One of the 2 cobalamin forms active in the body. Cyanocobalamin carries a cyanide group at the same position
Vitamin B6
Used
Pyridoxal 5'-phosphate
Usual alternative
Pyridoxine hydrochloride
Chemical difference
The phosphorylated coenzyme form
Riboflavin
Used
Riboflavin 5′-phosphate sodium
Usual alternative
Riboflavin
Chemical difference
Likewise the phosphorylated form; water-soluble
Vitamin K
Used
Menaquinone (K2)
Usual alternative
Phylloquinone (K1)
Chemical difference
A different molecule with a different side chain, not the same substance in another presentation
Vitamin E
Used
Mixed tocopherols · D-alpha-tocopheryl acetate
Usual alternative
dl-alpha-tocopheryl acetate
Chemical difference
D-alpha is the natural stereoform; dl-alpha is a mixture of 8 stereoisomers
Vitamin C
Used
Calcium L-ascorbate · L-ascorbyl 6-palmitate
Usual alternative
Ascorbic acid
Chemical difference
A salt and a fatty acid ester; neither is acidic
Zinc
Used
Zinc bisglycinate
Usual alternative
Zinc oxide, sulphate
Chemical difference
Chelate of zinc and 2 glycine molecules
Selenium
Used
Sodium selenite
Usual alternative
Selenomethionine, selenium yeast
Chemical difference
An inorganic selenium salt. Unlike selenomethionine it is not incorporated into body proteins in place of methionine
Chromium
Used
Chromium(III) chloride
Usual alternative
Chromium picolinate, nicotinate
Chemical difference
Trivalent chromium as an inorganic salt - the oxidation state in which chromium occurs in foods
Acetyl-L-carnitine
Used
Acetyl-L-carnitine hydrochloride
Usual alternative
L-carnitine, L-carnitine tartrate
Chemical difference
The acetylated form, stabilised as the hydrochloride
Quercetin
Used
Quercetin phospholipid powder
Usual alternative
Quercetin dihydrate
Chemical difference
Formulated with sunflower lecithin
Astaxanthin
Used
From the microalga (Haematococcus pluvialis)
Usual alternative
Synthetic astaxanthin
Chemical difference
Algal origin
Lutein · zeaxanthin
Used
From marigold extract (Tagetes)
Usual alternative
the same origin is usual
Chemical difference
-

The full assignment of all 35 components is in Annex A.

§ 4 What is not in it

4 omissions are decisions, not oversights.

An ingredients list is read by what is missing from it too.

Iron not included

Not included. Iron deficiency is common, a general need for iron is not - and substitution should be tied to a laboratory value and monitored, not to a preparation for daily use.

There is also tolerability. A meta-analysis of 43 randomised controlled trials with 6,831 adults found a doubling of gastrointestinal side effects for ferrous sulfate versus placebo (OR 2.32; 95 % CI 1.74-3.08).1 A Cochrane review of 67 studies with 8,506 women quantifies the individual symptoms and rates the evidence for them as high: hard stools and constipation RR 2.07 (1.35-3.17), loose stools RR 2.13 (1.10-4.11).2

In a preparation taken daily and without laboratory monitoring, iron is the component with the least favourable ratio of precision to tolerability.

Iodine not included

Not included. Where thyroid autonomy is present, additional iodine can trigger hyperthyroidism; iodine-induced thyroid dysfunction is described as a cause of thyrotoxicosis in its own right.3 A preparation for daily use also reaches those in whom autonomy is not known.

Calcium carrier salt only

Not declared as a nutrient. It occurs solely as a carrier salt in calcium L-ascorbate and calcium D-pantothenate. A dietary calcium deficiency is rare in this target group, and the amount that would make a contribution lies in the gram range - that is, outside what 4 capsules hold (§ 2).

Vitamin D: 50 µg (2,000 IU), no more

Included, but deliberately limited. The figure lies above the D-A-CH estimate of 20 µg (800 IU) for adolescents and adults in the absence of endogenous synthesis16 and at half the tolerable upper level of 100 µg (4,000 IU) derived by the EFSA.12

Higher daily doses cannot be justified in a preparation without measurement of levels, and still less for intake over years. The Endocrine Society guideline of 2024 advises against empirical supplementation above the reference intake in healthy adults under 75 (a conditional recommendation), and equally against routine 25(OH)D testing without indication.4

The figure chosen lies between the 2 marks - above the estimate, well below the upper level. That is the position that tolerates lasting intake without laboratory monitoring. Anyone who knows their level and needs more needs a single preparation - not a higher dose in a combination preparation.

§ 5 State of the evidence

Of 35 components, 18 carry a health claim authorised under European law. For the remaining 17 none is asserted - neither in this document nor on the pack nor in the sale.

The 18 are the vitamins and minerals. The 17 are everything else: coenzyme Q10, nicotinamide riboside, trans-resveratrol, acetyl-L-carnitine, alpha-lipoic acid, the carotenoids and the plant extracts.

“Not authorised” does not mean “not evidenced”

The distinction is not hair-splitting but the basis for judging this list.

An authorisation under Regulation (EC) No 1924/2006 is not an automatic result of the state of the research. It requires an application to have been filed, an applicant to fund it, and an assessment examining the causal relationship for exactly the composition applied for. A substance without an application stays without a claim - regardless of how much has been published on it.

The special case of the plant extracts

For botanical substances, assessment by the European Commission has been suspended since 2010. The corresponding claims sit on a so-called “on hold” list that was never decided.

The legal position has been settled since 2025, and settled in the strict direction. On 30 April 2025 the Court of Justice of the European Union ruled on a reference from the German Federal Court of Justice (C-386/23, Novel Nutriology GmbH v Verband Sozialer Wettbewerb e.V.). The operative part in its own words:

“Article 10(1) and (3) of Regulation (EC) No 1924/2006 […] must be interpreted, in the context of commercial advertising of a food supplement composed of ‘botanical substances’ […] as meaning that it is not permitted […] to use specific health claims relating to such substances […] or to make reference to the general, non-specific benefits of such a substance for overall good health and health-related well-being, until the European Commission has completed its examination […] unless the use of such claims is permitted under Article 28(6) of that regulation.”5

The operative part covers Article 10(3) as well - so not only the specific health claim but also the vague reference to “well-being”. The transitional rule in Article 28(6) applies only where an application was filed before 19 January 2008; in the original case the deadline had been missed.

For ashwagandha, Cordyceps, Hericium, hops, green tea, grape seed and rosehip the position is therefore without qualification: no claim, in any formulation. In this preparation they are stated with amount, extract form and characterising constituent - and with nothing else.

What follows from that

For 17 of the 35 components this document makes no statement about any effect. It names what is in it, in which form and in what amount. The judgement of whether any of these substances makes sense at this amount stays with the reader - and the reader has the same literature available as the manufacturer.

§ 6 Safety

Distance from the upper levels, interactions, labelling.

The figures below come from the opinions of the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), each from the primary source with its DOI. Several were reassessed in 2023 and 2024 and lowered in the process.

2 kinds of figure that are not the same thing. A tolerable upper intake level (UL) is derived from a dose-response relationship. Where the data did not allow that, the EFSA instead gave a safe level of intake and expressly noted that its application is more limited, because the threshold above which risk rises is not defined.6

Componentin ATLASFigureTypeShareSource
Vitamin E
in ATLAS
15.7 mg
Figure
300 mg
Type
UL
5 %
Source
Vitamin B6
in ATLAS
2.3 mg
Figure
12 mg
Type
UL
19 %
Source
Manganese
in ATLAS
2 mg
Figure
8 mg
Type
safe level of intake
25 %
Source
Selenium
in ATLAS
100 µg
Figure
255 µg
Type
UL
39 %
Source
Molybdenum
in ATLAS
101 µg
Figure
600 µg
Type
UL
17 %
Source
Folate
in ATLAS
400 µg
Figure
1,000 µg
Type
UL
40 %
Source
Zinc
in ATLAS
10 mg
Figure
25 mg
Type
UL
40 %
Source
Vitamin D
in ATLAS
50 µg
Figure
100 µg
Type
UL
50 %
Source

The highest figure in the table sits at half. That follows from the design for lasting intake (§ 2), not from chance in the formula.

For context: the UL for selenium rests on alopecia as the earliest observable effect, derived from the SELECT trial.10 The UL for vitamin D rests on persistent hypercalciuria.12 The UL for folate expressly applies to (6S)-5-methyltetrahydrofolic acid glucosamine salt as well - that is, exactly the form used here.11

8 of the 18 vitamins and minerals are listed here. The figures for zinc and molybdenum come from assessments by the Scientific Committee on Food of 2002 and 2000 and had not yet been revised in the course of the 2023/24 reassessment - which is why the year stands in the table.

For the remaining 10 - thiamine, riboflavin, niacin, pantothenic acid, biotin, vitamin B12, vitamin C, vitamin K, magnesium and chromium - there is no figure this document could name with a verified source. A figure without a verified source does not appear here.

On the iron section in § 4: in 2024 the EFSA was likewise unable to derive a UL for iron and instead gave a safe level of intake of 40 mg/day; the critical endpoint was black stools as an indication of large amounts of unabsorbed iron in the gut.13 The side effects described in § 4 occur at therapeutic substitution doses below that figure - the safety figure is no measure of tolerability.

Interactions that matter in substance

The warning “If you are taking medicines, the product should only be taken under medical supervision” is on every pack. These constellations make it concrete.

Vitamin E under anticoagulation - the EFSA expressly excludes this group. The critical effect on which the UL for vitamin E rests is impairment of blood clotting and an increased risk of bleeding with it. The opinion states that the upper levels do not apply to persons taking anticoagulants or platelet aggregation inhibitors (e.g. acetylsalicylic acid), nor to patients in secondary prevention of cardiovascular disease or with vitamin K malabsorption.7

This is the most important constellation in this section, because it overlaps with the next. The product contains vitamin E and vitamin K; both touch on coagulation, from opposite directions. Under ongoing anticoagulation, taking it should therefore not merely be mentioned but discussed.

Vitamin K and vitamin K antagonists. Menaquinone acts on the same metabolic pathway as phenprocoumon or warfarin. Under ongoing anticoagulation, a constant intake is the precondition for the adjustment to hold; newly started supplementation changes it. That is not a contraindication but a reason to tell the treating doctor.

Coenzyme Q10, coumarins and antihypertensives. The product contains 150 mg. The BfR considers clinically relevant interactions with coumarin-type anticoagulants and with blood pressure-lowering medicines not conclusively assessable, and advises these patients to seek medical advice above a daily dose of 100 mg.17 The constellation should therefore be discussed.

Vitamin K2 and coumarins. The product contains 150 µg menaquinone-7. Even 10 µg MK-7 daily lowered the INR to a clinically relevant degree in at least 40 % of subjects on acenocoumarol; the authors advise avoiding MK-7 during vitamin K antagonist therapy.18 Use should be discussed beforehand, with INR monitoring when starting and stopping.

Biotin and laboratory testing. The product contains 104 µg. Biotin can interfere with immunoassays based on biotin-streptavidin binding (TSH, fT3/fT4, troponin), upwards or downwards depending on the assay format.19 Patients should tell the laboratory before blood is drawn.

Ashwagandha, liver and thyroid. The product contains 90 mg extract with 5 mg withanolides. Rare cholestatic or mixed liver injury has been described after 2 to 12 weeks, at daily amounts of 450 to 1,350 mg according to the product labels, with liver values normalising within 1 to 5 months.20 Severe courses occurred in patients with pre-existing liver disease.21 600 mg root extract daily lowered TSH and raised T3 and T4 in subclinical hypothyroidism.22 Since 2024 the German Federal Institute for Risk Assessment has advised against ashwagandha products in general and names no safe intake;23 Denmark has not permitted ashwagandha in food supplements since 2020. In liver or thyroid disease, its use should be discussed beforehand.

Green tea extract. The product contains 33 mg EGCG. The warning not to consume it on the same day as other green tea products and not on an empty stomach is not the manufacturer being cautious but follows the European rules for green tea extracts containing EGCG. The same rules require the warning not to exceed a daily intake of 800 mg EGCG.

Ashwagandha. Not during pregnancy or breastfeeding - as declared. Where thyroid disease is present, taking it should be discussed.

Chromium alongside antidiabetic medicines. 50 µg are contained. There is no upper level for chromium that this document could name with a verified source - unlike for the 8 substances in the table above. The constellation should nevertheless be named.

Matters requiring declaration

Ashwagandha, Hericium and Cordyceps extract naturally contain sulphites. The product is not intended for pregnant or breastfeeding women or persons under 18 and should not be consumed on an empty stomach.

§ 7 Manufacturing and testing

Made in Lengau, Upper Austria. The plant is certified to an internationally recognised food safety standard (FSSC 22000). The Global Food Safety Initiative recognises it; it goes beyond the food safety required by law.

Amber glass instead of plastic. Light-sensitive components degrade under UV exposure; the glass holds it back. The desiccant sachet supplied belongs in the container, not in the bin - the product is moisture-sensitive. Use up within 6 months of opening.

Laboratory testing of every batch

Every batch is tested by an external laboratory. A batch is only sold once testing is complete. We publish the full, unedited test report for every batch on the Quality & Standards page, with the batch number printed on the container.

§ 8 Disclosure

This document comes from the manufacturer. Its author runs ATLAS Health as a sole proprietorship and has a commercial interest in the sale of the product described.

It contains no recommendation. It contains the composition, the compounds chosen, the reasoning behind the omissions, the distance from the applicable upper levels and the interactions to be considered before taking it. Where a statement could not be evidenced, it is not in here.

The judgement of whether this product makes sense for you or for the people in your care is not something this document can take off your hands - and it does not want to.

Q Sources

Each source below is documented with its identifier and date.

  1. Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 2015;10(2):e0117383. PMID 25700159 · doi.org/10.1371/journal.pone.0117383
  2. Low MSY, Speedy J, Styles CE, De-Regil LM, Pasricha SR. Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev 2016;4:CD009747. PMID 27087396 · doi.org/10.1002/14651858.CD009747.pub2
  3. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016;388(10047):906-918. PMID 27038492 · doi.org/10.1016/S0140-6736(16)00278-6 - names iodine-induced thyroid dysfunction expressly as a cause of thyrotoxicosis in its own right. As a more recent overall review: Chaker L, Cooper DS, Walsh JP, Peeters RP. Hyperthyroidism. Lancet 2024;403(10428):768-780. PMID 38278171 · doi.org/10.1016/S0140-6736(23)02016-0
  4. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2024;109(8):1907-1947. PMID 38828931 · doi.org/10.1210/clinem/dgae290
  5. Court of Justice of the European Union, judgment of 30 April 2025, Case C-386/23 (Novel Nutriology GmbH v Verband Sozialer Wettbewerb e.V.), ECLI:EU:C:2025:304, on a reference from the German Federal Court of Justice.
  6. EFSA NDA Panel. Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals. EFSA Journal 2024;22(11):e9052 · doi.org/10.2903/j.efsa.2024.9052
  7. EFSA NDA Panel (Turck D, Bohn T, Castenmiller J, et al.). Scientific opinion on the tolerable upper intake level for vitamin E. EFSA Journal 2024;22(8):e8953. PMID 39099617 · doi.org/10.2903/j.efsa.2024.8953
  8. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for vitamin B6. EFSA Journal 2023;21(5):e08006. PMID 37207271 · doi.org/10.2903/j.efsa.2023.8006 - UL 12 mg/day (previously 25), critical effect peripheral neuropathy.
  9. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for manganese. EFSA Journal 2023;21(12):e8413. PMID 38075631 · doi.org/10.2903/j.efsa.2023.8413 - no UL derivable, safe level of intake 8 mg/day.
  10. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for selenium. EFSA Journal 2023;21(1):e07704. PMID 36698500 · doi.org/10.2903/j.efsa.2023.7704 - UL 255 µg/day (previously 300), LOAEL 330 µg from the SELECT trial.
  11. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for folate. EFSA Journal 2023;21(11):e08353. PMID 37965303 · doi.org/10.2903/j.efsa.2023.8353
  12. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journal 2023;21(8):e08145. PMID 37560437 · doi.org/10.2903/j.efsa.2023.8145 - UL 100 µg/day, critical endpoint persistent hypercalciuria.
  13. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for iron. EFSA Journal 2024;22(6):e8819. PMID 38868106 · doi.org/10.2903/j.efsa.2024.8819 - no UL derivable, safe level of intake 40 mg/day.
  14. Scientific Committee on Food (SCF). Opinion on the tolerable upper intake level of zinc, adopted on 5 March 2003 - UL 25 mg/day for adults. Not yet revised in the course of the 2023/24 reassessment.
  15. Scientific Committee on Food (SCF). Opinion on the tolerable upper intake level of molybdenum, 2000 - UL 600 µg/day for adults, derived from 10 µg per kg of body weight at 60 kg (NOAEL 0.9 mg/kg from rat studies, uncertainty factor 100). Likewise not yet revised.
  16. German, Austrian and Swiss nutrition societies. D-A-CH reference values for nutrient intake, vitamin D, as at 2012 - estimate 20 µg (800 IU) per day for adolescents from 15 years and adults in the absence of endogenous synthesis.
  17. German Federal Institute for Risk Assessment (BfR). Coenzyme Q10: what is known about health risks - and what is not? Questions and answers of 10 November 2023, in German · bfr.bund.de/fragen-und-antworten/thema/coenzym-q10-was-ist-ueber-gesundheitliche-risiken-bekannt-und-was-nicht
  18. Theuwissen E, Teunissen KJ, Spronk HMH et al. Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. J Thromb Haemost 2013;11(6):1085-92 · PMID 23530987 · doi.org/10.1111/jth.12203
  19. Dasgupta A. Immunoassay design and biotin interference. Adv Clin Chem 2022;109:165-183 · PMID 35953126 · doi.org/10.1016/bs.acc.2022.03.005
  20. Björnsson HK, Björnsson ES, Avula B et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int 2020;40(4):825-829 · PMID 31991029 · doi.org/10.1111/liv.14393
  21. Philips CA, Valsan A, Theruvath AH et al. Ashwagandha-induced liver injury - A case series from India and literature review. Hepatol Commun 2023;7(10) · PMID 37756041 · doi.org/10.1097/HC9.0000000000000270
  22. Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med 2018;24(3):243-248 · PMID 28829155 · doi.org/10.1089/acm.2017.0183
  23. German Federal Institute for Risk Assessment (BfR). Ashwagandha: sleeping berry preparations with possible health risks. Communication No. 039/2024 of 10 September 2024 (in German) · bfr.bund.de/cm/343/ashwagandha-schlafbeeren-praeparate-mit-moeglichen-gesundheitsrisiken.pdf

All 23 sources have been retrieved individually and verified with PMID, DOI, ECLI, the panel decision or the authority's statement together with its date.

Food supplements are not a substitute for a balanced and varied diet and a healthy lifestyle. The recommended daily intake must not be exceeded. Keep out of the reach of children.